Edition:
United Kingdom

People: CHF Solutions Inc (CHFS.OQ)

CHFS.OQ on NASDAQ Stock Exchange Capital Market

2.19USD
4:29pm BST
Change (% chg)

$-0.01 (-0.45%)
Prev Close
$2.20
Open
$2.18
Day's High
$2.20
Day's Low
$2.11
Volume
5,045
Avg. Vol
15,944
52-wk High
$18.76
52-wk Low
$2.08

Erb, John 

Mr. John L. Erb is Chairman of the Board, President, Chief Executive Officer of the Board of the Company. John L. Erb currently serves as chief executive officer and president and has served as a director of the Company since September 2012 and as Chairman of the Board since October 2012. He is currently chief executive officer of NuAx, Inc. (formerly Cardia Access, Inc.), a medical device company involved in developing new devices for the treatment of heart disease, a position he has held since February 2007. Previously, Mr. Erb served as executive chairman of the board (during 2007) and as chief executive officer (from 2001 to 2006) of CHF Solutions, Inc., a medical device company involved in the development, manufacturing and distribution of devices to treat congestive heart failure; as president and chief executive officer of IntraTherapeutics, Inc., a medical device company involved in the development, manufacturing and distribution of peripheral vascular stents, from 1997 to 2001; and in various positions, including vice president of worldwide operations, at Schneider, a division of Pfizer, Inc., from 1991 to 1997. Mr. Erb’s prior board experience includes service as a director of SenoRx, Inc., a publicly traded company, from December 2001 to July 2010, service as a director of CryoCath Technologies Inc., a publicly traded Canadian company, from October 2000 to December 2008, and service as director of Vascular Solutions, Inc. (a Nasdaq listed company) from 2002 to February 2017. While on the board of Vascular Solutions, Mr. Erb served as Chairman of the Board of Directors, chairman of the compensation committee, and of the nominating and corporate governance committees. Mr. Erb currently serves as a director of NuAx, as well as Osprey Medical, Inc. (listed on the Australian Securities Exchange; serves as chairman of the compensation committee and a member of the audit committee), Mr. Erb received a B.A. degree in business administration, with a concentration in finance from California State University,

Basic Compensation

Total Annual Compensation, USD 385,833
Restricted Stock Award, USD 331,044
Long-Term Incentive Plans, USD --
All Other, USD 497,227
Fiscal Year Total, USD 1,214,100

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --